Building Digital Twin Tools To Investigate Environmental Threats to Health
A UF research team is developing Florida’s Digital Twin, a digital replica of Florida that can model the effects of natural disasters and future health threats, to understand the complexity of how environmental factors affect human health, with a grant from the NIH's National Institute of Environmental Health Sciences.
What the Trained Eye Cannot See: Detecting Movement Defects in Early-Stage Parkinson’s Disease
A technique that uses videos and machine learning to quantify motor symptoms in early-stage Parkinson’s disease could help reveal signs of the disease and other movement disorders earlier, which could lead to better treatment outcomes.
UF-Developed Genetic Score Improves Outcomes by Personalizing Leukemia Therapy
Using patients’ own genetics to tailor their chemotherapy regimens appears to improve outcomes in children with acute myeloid leukemia, a pediatric cancer for which treatment has gone unchanged for 50 years, a new University of Florida Health-led study shows.
MBI Researchers to Test Novel Treatments for Medulloblastoma
University of Florida researchers have received approval from the Food and Drug Administration to test two new experimental therapies in first-ever human clinical trials for a subtype of medulloblastoma, the most common pediatric malignant brain tumor.
UF Smart Sensor Sends Smartphone Alert if Mending Patient Too Daring on Their Feet
UF Health foot and ankle surgeon R. James Toussaint and UF engineering professor Swarup Bhunia have invented a new wearable smart sensor that sends doctors and patients real-time alerts if a healing patient puts too much weight on a surgically repaired foot.
UF-Developed mRNA Vaccine Triggers Fierce Immune Response To Fight Malignant Brain Tumor
In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine developed at the University of Florida quickly reprogrammed the immune system to attack glioblastoma, the most aggressive and lethal brain tumor.
UF Team Plays Major Role in Success of Newly Approved Duchenne Muscular Dystrophy Drug
Duchenne muscular dystrophy families, advocates and healthcare providers celebrated a milestone in March with the U.S. Food and Drug Administration’s approval of the first nonsteroidal drug for the treatment of Duchenne. The University of Florida's expertise in magnetic resonance imaging provided objective, measurable results in the drug's clinical trials.
UF-Led Study Could Lead to New Way To Detect Brain Changes Associated With Alzheimer’s Risk
New research suggests there may be a link between abnormal blood levels of amyloid — a protein associated with Alzheimer's disease — and subtle changes in the brain microstructures.
The researchers found, through a new MRI method called diffusion MRI, or "free-water imaging", an association in those with abnormal amyloid levels in the blood and structural abnormalities in the brain.
Osteoarthritis Gene Therapy Research Honored With OREF Award
The founders of Genascence, a UF Innovate | Accelerate gene therapy startup, have been awarded with the 2024 Orthopaedic Research and Education Foundation (OREF) Clinical Research Award for their research on local gene therapy for osteoarthritis (OA). Over the past 30 years, the team has spearheaded research from the lab to human critical trials. This award recognizes outstanding clinical research related to musculoskeletal disease or injury.
UF Health Recognized As National Leader for Treatment of Rare Inherited Disorder
UF Health has become one of only 40 VHL Alliance Clinical Care Centers in the United States.
The VHL Alliance is made up of leading healthcare organizations that specialize in treating von Hippel-Lindau (VHL) syndrome, a rare inherited disorder associated with tumors.
Hans Shuhaiber, M.D., a clinical assistant professor in the department of neurology in the UF College of Medicine and a member of the UF Health Cancer Center, said this recognition will ensure patients have access to the best treatment when they come to UF Health.
